Harbor Advisory Corp Abb Vie Inc. Transaction History

Harbor Advisory Corp

$305 Million
Q3 2024

A detailed history of Harbor Advisory Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Harbor Advisory Corp holds 24,145 shares of ABBV stock, worth $4.24 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

24,145

Previous 23,895 1.05%

Holding current value

$4.24 Million

Previous $4.1 Million 16.35%

% of portfolio

1.56%

Previous 1.42%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$163.84 - $199.33 $40,960 - $49,832	250 Added 1.05%	24,145 $4.77 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $248,128 - $289,758	-1,603 Reduced 6.29%	23,895 $4.1 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $76,873 - $87,590	-481 Reduced 1.85%	25,498 $4.64 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $89,440 - $100,730	-650 Reduced 2.44%	25,979 $4.03 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $41,680 - $48,250	-312 Reduced 1.16%	26,629 $3.97 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $15,503 - $19,293	-117 Reduced 0.43%	26,941 $3.63 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $138,102 - $159,045	-955 Reduced 3.41%	27,058 $4.31 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $3.87 Million - $4.65 Million	28,013 New	28,013 $4.53 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $296,738 - $340,339	2,211 Added 8.83%	27,253 $3.66 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $91,792 - $116,698	667 Added 2.74%	25,042 $3.84 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $133,959 - $166,206	-1,015 Reduced 4.0%	24,375 $3.95 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $1.15 Million - $1.45 Million	10,682 Added 72.63%	25,390 $3.44 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $268,660 - $304,969	2,525 Added 20.73%	14,708 $1.59 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $810,117 - $902,517	7,700 Added 171.76%	12,183 $1.37 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $153,450 - $168,930	1,500 Added 50.28%	4,483 $485,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $240,101 - $324,162	2,983 New	2,983 $320,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisory Corp , based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisory Corp with notifications on news.

Account

Harbor Advisory Corp Abb Vie Inc. Transaction History